Soft Tissue Sarcoma (Excluding GIST)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Soft Tissue Sarcoma (Excluding GIST) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT07169344

Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma

The purpose of the study is to investigate whether a personalized selection of patients with localized soft tissue sarcoma for preoperative proton radiation the…

Norway110 participantsStarted 2026-01-26

Treatment: preoperative, Quality of life

All recent trials (4 shown)

Not Yet RecruitingPhase 2

NCT07507773

Assessment of the Long-term Efficacy of Moderately Hypofractionated Neoadjuvant Radiotherapy Soft Tissue Sarcoma in the…

This trial aims to assess the long-term efficacy of moderately hypofractionated neoadjuvant radiotherapy for soft tissue sarcoma in the limbs or trunk wall. The…

France135 participantsStarted 2026-04-01

Treatment: Moderately hypofractionated neoadjuvant radiotherapy

Not Yet RecruitingPhase 2

NCT07457775

Liposomal Irinotecan in Combination With Temozolomide and Bevacizumab in Patients With Advanced STS

The study is expected to include 24 patients with metastatic or surgically unresectable relapsed/refractory soft tissue sarcoma confirmed by histological eviden…

China24 participantsStarted 2026-03-31

Treatment: Irinotecan Hydrochloride Liposome Injection(II) combined with temozolomide and bevacizuma

Soft Tissue Sarcoma (Excluding GIST)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma

All recent trials (4 shown)

Assessment of the Long-term Efficacy of Moderately Hypofractionated Neoadjuvant Radiotherapy Soft Tissue Sarcoma in the…

Liposomal Irinotecan in Combination With Temozolomide and Bevacizumab in Patients With Advanced STS

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma

All recent trials (4 shown)

Assessment of the Long-term Efficacy of Moderately Hypofractionated Neoadjuvant Radiotherapy Soft Tissue Sarcoma in the…

Liposomal Irinotecan in Combination With Temozolomide and Bevacizumab in Patients With Advanced STS

Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors